IssuerAnnouncementDetailsV2Portlet
Actions
Future Vision for Health Training Co. Board invites its shareholders to attend the Extraordinary General Assembly Meeting the (First Meeting)
| Element List | Explanation |
|---|---|
| Introduction | The Board of Directors of Roya Al-Mustaqbal for Health Training Company is pleased to invite the esteemed shareholders to participate and vote in the Extraordinary General Assembly Meeting (First Meeting). The meeting is scheduled, God willing, to be held at 7:30 PM on Sunday, 04/01/1447H, corresponding to 29/06/2025G, via modern technological means. |
| City and Location of the General Assembly's Meeting | The General Assembly meeting will be held remotely via modern technological means at the company’s headquarters located in Al-Qalbatein District, Abu Bakr Al-Siddiq Road, Madinah |
| Hyperlink of the Meeting Location | Click Here |
| Date of the General Assembly's Meeting | 2025-06-29 Corresponding to 1447-01-04 |
| Time of the General Assembly’s Meeting | 19:30 |
| Methodology of Convening the General Assembly’s Meeting | Via modern technology means |
| Attendance Eligibility, Registration Eligibility, and Voting End | Shareholders who are registered in the issuers shareholders record at the Depositary Center by the end of the trade session prior to the general assembly meeting and in accordance with the laws and regulations. The shareholder has the right to delegate whomever other than the board of directors. The right to register a name to attend the general assembly meeting ends at the time of convening the general assembly meeting. The attendees right to vote on the items of the assembly’s agenda ends upon the end of screening the votes by the Screening Committee. |
| Quorum for Convening the General Assembly's Meeting | In accordance with Article (43) of the Company’s Articles of Association, the Extraordinary General Assembly meeting shall be valid if attended by shareholders representing at least 50% of the company’s capital. If the required quorum for the first meeting is not met, a second meeting shall be held one hour after the end of the scheduled time of the first meeting. The second meeting shall be valid if attended by shareholders representing at least 25% of the company’s capital. |
| General Assembly Meeting Agenda | 1- Vote on amending the company’s Articles of Association to reflect recent updates following its listing on the financial market, including: -Amending the company name to: Future Vision for Health Training Co. – A Listed Joint Stock Company. -Amending the company’s capital from SAR 8,000,000 to SAR 10,000,000. 2- Vote on amending the company’s objectives by adding the activities of management consulting and higher institute services. 3- Vote on the company’s auditor report for the fiscal year ending December 31, 2024 (attached) 4- Vote on the Board of Directors’ report for the fiscal year ending December 31, 2024 (attached) 5- Vote on and discuss the company’s financial statements for the fiscal year ending December 31, 2024 (attached). 6- Vote on discharging the Board members from liability for the fiscal year ending December 31, 2024. 7- Vote on the company's purchase of up to 350,000 of its ordinary shares to be held as treasury shares for multiple purposes, in line with applicable laws and based on Article (9) of the Articles of Association, supported by the external auditor’s solvency report. The purchase will be funded from the company’s internal resources, and the Board of Directors is authorized to execute the purchase within 12 months from the date of the Extraordinary General Assembly resolution. Share purchase breakdown: 200,000 shares as treasury stock, Where the Board of Directors deems that the market price of the share is below its fair value 150,000 shares allocated to the Employee Stock Incentive Program, aiming to boost institutional loyalty, attract talent, and retain employees. Shares are to be retained for no more than five years from the EGA’s approval date. If not sold or allocated within this period, the company will take legal measures to cancel them within six months after the period ends, unless an extension is approved by the EGA. 8- Vote on establishing the Employee Share Program and authorizing the Board of Directors to define its terms and conditions, including but not limited to: eligible employee categories, number of allocated shares, vesting conditions, allocation price (if applicable), and any other relevant terms. 9- Vote on appointing the company’s auditor from among the nominated candidates, based on the Audit Committee's recommendation, to review and audit the financial statements for the half-year ending June 30, 2025, and the full year ending December 31, 2025, for a total fee of SAR 131,100 (attached). |
| Proxy Form |  |
| The shareholder right in discussing the assembly agenda topics, asking questions, and exercising the voting right | Shareholders attending the meeting have the right to discuss the items listed on the agenda and raise questions. Shareholders registered in Tadawulaty services may vote electronically and remotely on the assembly’s agenda items starting through the following link: https://www.tadawulaty.com.sa |
| Details of the electronic voting on the Assembly’s agenda | Registered shareholders in Tadawulaty services will be able to remotely vote on the items of the Extraordinary General Assembly through the (e-voting) service, which will start at 01:00 AM on Wednesday, 29 Dhul-Hijjah 1446H, corresponding to 25-06-2025, and will continue until the end of the assembly meeting. Registration and voting through Tadawulaty services will be available and free of charge for all shareholders via the following link: (https://www.tadawulaty.com.sa) |
| Method of Communication in Case of Any Enquiries | If you have any inquiries, please do not hesitate to contact the Shareholders Relations Department at: IR@fv.academy |
| Attached Documents | |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
Key Parameters
Last Price 5.7
Net Change -0.1 (-1.72%)
Value Traded (Sar) 255,588.4
Volume Traded 44,350
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions